Bret Scholtes's Insider Trades & SAST Disclosures

Bret Scholtes's most recent trade in Guardion Health Sciences Inc was a trade of 37,175 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on Jan. 6, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Guardion Health Sciences Inc
Bret Scholtes Director, CEO and President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. 06 Jan 2022 37,175 294,980 (0%) 0% 0.7 24,164 Common Stock
Guardion Health Sciences Inc
Bret Scholtes Director, CEO and President Purchase of securities on an exchange or from another person at price $ 1.23 per share. 30 Aug 2021 5,500 179,484 (0%) 0% 1.2 6,760 Common stock
Guardion Health Sciences Inc
Bret Scholtes Director, CEO and President Purchase of securities on an exchange or from another person at price $ 1.26 per share. 30 Aug 2021 4,500 173,984 (0%) 0% 1.3 5,656 Common stock
Guardion Health Sciences Inc
Bret Scholtes Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2021 916,023 916,023 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades